Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy;Fatores de risco para incapacidade física no momento do diagnóstico de 19.283 casos novos de hanseníase

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 1, 2010, Pages 19-22

  Moschioni, Cristiane ^a   Antunes, Carlos Maurício de Figueiredo ^a   Grossi, Maria Aparecida Faria ^b   Lambertucci, José Roberto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Health State Office of Minas Gerais   (Brazil)

Author keywords

Lepromatous leprosy; Leprosy; Physical disability; Physical disability prognosis; Risk factors for disability

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BORDERLINE LEPROSY; BRAZIL; DIAGNOSTIC TEST; FEMALE; HUMAN; LEPROMATOUS LEPROSY; MAJOR CLINICAL STUDY; MALE; MULTIBACILLARY LEPROSY; PATIENT EDUCATION; PHYSICAL DISABILITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 77950937941     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822010000100005     Document Type: Article

References (34)

1. Meima A, Richardus JH, Habbema JD. Trends in leprosy case detection worldwide since 1985. Lepr Rev 2004; 75:19-33.
2. World Health Organization. Global leprosy situation, 2004. Wkly Epidemiol Rec 2005; 80:118-124.
3. Suárez REG and Lombardi C. Estimado de prevalência de lepra. Hansen Int 1997; 22: 31-34.
4. Opromolla DVA. A hanseníase após a cura [Editorial]. Hansen Int 1998; 23:1-2.
5. Smith WC, Antin US, Patole AR. Disability in leprosy: a relevant measurement of progress in leprosy control. Lepr Rev 1980; 51:155-166.
6. World Health Organization. Leprosy elimination campaigns. Wkly Epidemiol Rec 2000; 75:361-366.
7. Pfaltzgraff RE, Bryceson A. Clinical leprosy. In: Hastings RC. Leprosy. New York: Churchill Livingstone; 1985. p.134-176.
8. Spierings E, de Boer T, Wieles B, Adams LB, Marani E, Ottenhoff TH. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy. J Immunol 2001; 166:5883-5888.
9. Job CK. Pathology and pathogenesis of leprous neuritis; a preventable and treatable complication. Int J Lepr Other Mycobact Dis 2001; 69 (supp l):S19-29.
10. Garbino JA, Nery JA, Virmond M, Stump PRN, Baccarelli R, Marques Junior W. Hanseníase: diagnóstico e tratamento da neuropatia. In: Associação Médica Brasileira, Conselho Federal de Medicina. Projeto diretrizes. São Paulo: AMB; 2005. p.147-59.
11. Smith WC. The epidemiology of disability in leprosy including risk factors. Lepr Rev 1992; 63 (suppl 1):23s-30s.
12. Saunderson P, Gebre S, Desta K, Byass P, Lockwood DN. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev 2000; 71:285-308.
13. Solomon S, Kurian N, Ramadas P, Rao PS. Incidence of nerve damage in leprosy patients treated with MDT. Int J Lepr Other Mycobact Dis 1998; 66:451-456.
14. Rodrigues ALP, Almeida AP, Rodrigues BF, Pinheiro CA, Borges DS, Mendonça MLH, et al. Occurrence of late lepra reaction in leprosy patients: subsidies for implementation of a specific care program. Hansen Int 2000; 25:17-25.
15. Croft RP, Richardus JH, Nicholls PG, Smith WC. Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study). Lepr Rev 1999; 70:140-159.
16. Zhang G, Li W, Yan L, Yang Z, Chen X, Zheng T, et al. An epidemiological survey of deformities and disabilities among 14,257 cases of leprosy in 11 counties. Lepr Rev 1993; 64:143-149.
17. Irgens LM. Leprosy in Norway: an epidemiological study based on a national patient registry. Lepr Rev 1980; 51(suppl 1):i-xi, 1-130
18. Kushwah SS, Govila AK, Kushwah J. An epidemiological study of disabilities among leprosy patients attending leprosy clinic in Gwalior. Leprosy 1981; 53:240-247.
19. Sehgal VN, Sharma PK. Pattern of deformities/disabilities in urban leprosy. Indian J Lepr 1985; 57:183-92.
20. Foss NT, Souza CS, Goulart IMB, Gonçalves HS, Virmond M. Hanseníase: Episódios reacionais. In: Associação Médica Brasileira, Conselho Federal de Medicina. Projeto diretrizes. São Paulo: AMB; 2005. p.161-179.
21. Van Brakel WH, Khawas IB. Nerve damage in leprosy: an epidemiological and clinical study of 396 patients in west Nepal. Part 1. Definitions, methods and frequencies. Lepr Rev 1994; 65:204-21.
22. Irgens LM, Skjaerven R. Secular trends in age at onset, sex ratio, and type index in leprosy observed during declining incidence rates. Am J Epidemiol 1985; 122:695-705.
23. Jain S, Reddy RG, Osmani SN, Lockwood DN, Suneetha S. Childhood leprosy in an urban clinic, Hyderabad, India: clinical presentation and the role of household contacts. Lepr Rev 2002; 73:248-253.
24. Li HY, Pan YL, Wang Y. Leprosy control in Shandong Province, China, 1955-1983; some epidemiological features. Int J Lepr Other Mycobact Dis 1985; 53:79-85.
25. Reddy BN, Bansal RD. An epidemiological study of leprosy disability in a leprosy endemic rural population of Pondicherry (south India). Indian J Lepr 1984; 56:191-199.
26. Kartikeyan S, Chaturvedi RM. Pattern of leprosy deformities among agricultural labourers in an endemic district: a pilot study. Indian J Lepr 1992; 64:375-379.
27. Kaur H, Van Brakel W. Dehabilitation of leprosy-affected people: a study on leprosy-affected beggars. Lepr Rev 2002; 73:346-355.
28. Noordeen SK. Epidemiology and control of leprosy-a review of progress over the last 30 years. Trans R Soc Trop Med Hyg 1993; 87:515-517.
29. Rao PS, Karat S, Karat AB, Furness MA. Prevalence of deformities and disabilities among leprosy patients in an endemic area. I. General findings. Int J Lepr Other Mycobact Dis 1970; 38:1-11.
30. Chen XS, Li WZ, Jiang C, Ye GY. Leprosy in China: epidemiological trends between 1949 and 1998. Bull World Health Organ 2001; 79:306-312.
31. Lombardi C, Martolli CM, Silva SA, Suárez RE. Eradication of leprosy in the Americas: current status and perspectives. Rev Panam Salud Publica. 1998; 4:149-155
32. Goulart IMB, Dias CM, Oliveira ACS, Silva AA, Alves RR, Quaresemin CR, et al. Grau de incapacidade: indicador de prevalência oculta e qualidade do programa de controle da hanseníase em um Centro de Saúde-Escola no município de Uberlândia-MG. Hansen Int 2002; 27:5-13.
33. Prata PB, Bohland AK, Vinhas SA. Aspectos epidemiológicos da hanseníase em localidades do Estado de Sergipe, Brasil, período de 1994-1998. Hansen Int 2000; 25:49-53.
34. Wu XS, Ning Y, Shi L, Jin Z, Yang JW. An epidemiological analysis of leprosy from 1951-1996 in Sichuan. Indian J Lepr 2000; 72:215-226.